• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国中部地区慢性骨髓炎的多中心流行病学分布、病原体及耐药特征

Multicenter epidemiological distribution, pathogens, and drug-resistance characteristics of chronic osteomyelitis in Central China.

作者信息

Liu Zemin, Jin Guochao, Zhang Le, Zhang Ruqi, Wang Dong, Liu Min, Li Yan, Zhang Yonghong

机构信息

Second Clinical Medical College, Shanxi Medical University, Taiyuan, China.

Department of Orthopaedics, Second Hospital of Shanxi Medical University, Taiyuan, China.

出版信息

Front Public Health. 2025 Aug 29;13:1654861. doi: 10.3389/fpubh.2025.1654861. eCollection 2025.

DOI:10.3389/fpubh.2025.1654861
PMID:40951409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12426033/
Abstract

INTRODUCTION

The incidence of chronic osteomyelitis increases annually. Currently, epidemiological data on chronic osteomyelitis in Central China are scarce. Describing the epidemiological distribution, pathogens, and drug resistance characteristics of patients with chronic osteomyelitis in Central China is critical for its prevention and control. In this study, we aimed to statistically analyze patients with chronic osteomyelitis from four local hospitals to provide a reference for prevention and control in this region.

METHODS

We conducted a retrospective analysis of the clinical data of patients with chronic osteomyelitis admitted to four hospitals in Central China between January 1, 2016, and December 31, 2021, using ICD codes in the electronic medical record system. Data extracted included patients' basic details, hospitalization records, infection status, and bacterial culture results. Statistical descriptions included pathogen detection, distribution, and changes. Furthermore, we analyzed the antibiotic resistance of Gram-positive and -negative bacteria. Patients with positive cultures underwent risk-factor analysis.

RESULTS

We included 632 patients with chronic osteomyelitis, comprising traumatic osteomyelitis (464 patients), hematogenous osteomyelitis (120 patients), and diabetic foot osteomyelitis (48 patients). The median age was 46 (IQR 30-58) years, and the majority were aged between 41 and 60 years. The male-to-female ratio was 2.49:1. Traffic accidents were identified as the primary etiological factor. The three most commonly affected sites were the tibia, femur, and calcaneus. Among the laboratory indicators, the erythrocyte sedimentation rate had the highest positive rate at 57.71%. Bacterial cultures were performed on the intraoperative specimens of 421 patients and yielded 292 positives (69.36%), of which we identified 386 isolates from 74 pathogens. The most prevalent pathogen were , , and spp. (132 [34.20%], 47 [12.18%], and 25 [6.47%] isolates). Gram-positive bacteria were resistant to conventional antibiotics, including penicillin, erythromycin, and clindamycin; however, they were susceptible to peptide antibiotics and oxazolidinones. Gram-negative bacteria were resistant to first- and second-generation cephalosporins; nevertheless, they were sensitive to third- and fourth-generation cephalosporins as well as combinations such as cefoperazone-sulbactam. Multivariate logistic regression analysis identified length of hospital stay (odds ratio [OR] = 1.037,  = 0.001), diabetes (OR = 6.61,  = 0.049), and smoking (OR = 6.873,  = 0.003) as independent risk factors.

CONCLUSION

Chronic osteomyelitis predominantly affects middle-aged and older adults, males, and those with tibial injuries from traffic accidents requiring special attention. was associated with the highest risk of infection. Empirical early-phase medication should be followed by targeted antibiotic therapy based on bacterial sensitivity and resistance. Patients with prolonged hospitalization, diabetes, or a smoking history require special attention. Notably, strengthening health education and postoperative care in these patients can reduce the risk of chronic osteomyelitis.

摘要

引言

慢性骨髓炎的发病率逐年上升。目前,中国中部地区关于慢性骨髓炎的流行病学数据匮乏。描述中国中部地区慢性骨髓炎患者的流行病学分布、病原体及耐药特征对其防控至关重要。在本研究中,我们旨在对来自四家当地医院的慢性骨髓炎患者进行统计分析,为该地区的防控工作提供参考。

方法

我们利用电子病历系统中的ICD编码,对2016年1月1日至2021年12月31日期间在中国中部四家医院收治的慢性骨髓炎患者的临床资料进行回顾性分析。提取的数据包括患者的基本信息、住院记录、感染状况及细菌培养结果。统计描述包括病原体检测、分布及变化情况。此外,我们分析了革兰氏阳性菌和阴性菌的抗生素耐药性。对培养阳性的患者进行危险因素分析。

结果

我们纳入了632例慢性骨髓炎患者,包括创伤性骨髓炎(464例)、血源性骨髓炎(120例)和糖尿病足骨髓炎(48例)。中位年龄为46岁(四分位间距30 - 58岁),大多数患者年龄在41至60岁之间。男女比例为2.49:1。交通事故被确定为主要病因。三个最常受累部位是胫骨、股骨和跟骨。在实验室指标中,红细胞沉降率的阳性率最高,为57.71%。对421例患者的术中标本进行细菌培养,292例呈阳性(69.36%),其中我们从74种病原体中鉴定出386株分离菌。最常见的病原体是[此处原文缺失具体病原体名称]、[此处原文缺失具体病原体名称]和[此处原文缺失具体病原体名称]菌属(分别为132株[34.20%]、47株[12.18%]和25株[6.47%]分离菌)。革兰氏阳性菌对包括青霉素、红霉素和克林霉素在内的传统抗生素耐药;然而,它们对肽类抗生素和恶唑烷酮敏感。革兰氏阴性菌对第一代和第二代头孢菌素耐药;不过,它们对第三代和第四代头孢菌素以及头孢哌酮 - 舒巴坦等联合用药敏感。多因素逻辑回归分析确定住院时间(比值比[OR]=1.037,P = 0.001)、糖尿病(OR = 6.61,P = 0.049)和吸烟(OR = 6.873,P = 0.003)为独立危险因素。

结论

慢性骨髓炎主要影响中老年男性以及因交通事故导致胫骨受伤的人群,需要特别关注。[此处原文缺失具体内容]与最高感染风险相关。经验性早期用药后应根据细菌敏感性和耐药性进行针对性抗生素治疗。住院时间延长、患有糖尿病或有吸烟史的患者需要特别关注。值得注意的是,加强对这些患者的健康教育和术后护理可降低慢性骨髓炎的风险。

相似文献

1
Multicenter epidemiological distribution, pathogens, and drug-resistance characteristics of chronic osteomyelitis in Central China.中国中部地区慢性骨髓炎的多中心流行病学分布、病原体及耐药特征
Front Public Health. 2025 Aug 29;13:1654861. doi: 10.3389/fpubh.2025.1654861. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
5
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4.
6
Microbial isolates and resistance profiles in cerebrospinal fluid cultures: a five-year experience at a tertiary center.脑脊液培养中的微生物分离株与耐药谱:一家三级医疗中心的五年经验
Future Microbiol. 2025 Jul;20(10):669-680. doi: 10.1080/17460913.2025.2520666. Epub 2025 Jun 18.
7
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD003543. doi: 10.1002/14651858.CD003543.pub3.
8
Organism profiles and empirical treatments for periprosthetic joint infections.人工关节感染的病原体概况及经验性治疗
J Orthop Surg Res. 2025 Jul 25;20(1):698. doi: 10.1186/s13018-025-06007-4.
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
Antibiotics for treating chronic osteomyelitis in adults.用于治疗成人慢性骨髓炎的抗生素。
Cochrane Database Syst Rev. 2013 Sep 6;2013(9):CD004439. doi: 10.1002/14651858.CD004439.pub3.

本文引用的文献

1
The role of bacterial metabolism in antimicrobial resistance.细菌代谢在抗菌药物耐药性中的作用。
Nat Rev Microbiol. 2025 Feb 20. doi: 10.1038/s41579-025-01155-0.
2
ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro.ESKAPE病原体在体外对正在研发的抗生素迅速产生耐药性。
Nat Microbiol. 2025 Feb;10(2):313-331. doi: 10.1038/s41564-024-01891-8. Epub 2025 Jan 13.
3
Understanding the impact of diabetes on bone health: A clinical review.了解糖尿病对骨骼健康的影响:一项临床综述。
Metabol Open. 2024 Nov 8;24:100330. doi: 10.1016/j.metop.2024.100330. eCollection 2024 Dec.
4
Antibiotic resistant bacteria survive treatment by doubling while shrinking.抗生素耐药细菌通过在缩小的同时加倍来在治疗中存活。
mBio. 2024 Dec 11;15(12):e0237524. doi: 10.1128/mbio.02375-24. Epub 2024 Nov 20.
5
Clinical features of chronic tibial osteomyelitis: a single-center retrospective study of 282 cases in Xinjiang, China.中国新疆地区 282 例慢性胫骨骨髓炎的临床特征:一项单中心回顾性研究。
BMC Musculoskelet Disord. 2024 Oct 19;25(1):823. doi: 10.1186/s12891-024-07928-7.
6
Nicotine promotes pathogenic bacterial growth and biofilm formation in peri-implant.尼古丁促进种植体周病病原菌生长和生物膜形成。
J Med Microbiol. 2024 Oct;73(10). doi: 10.1099/jmm.0.001897.
7
Nicotine promotes Staphylococcus aureus-induced osteomyelitis by activating the Nrf2/Slc7a11 signaling axis.尼古丁通过激活 Nrf2/Slc7a11 信号轴促进金黄色葡萄球菌诱导的骨髓炎。
Int Immunopharmacol. 2024 Jun 30;135:112223. doi: 10.1016/j.intimp.2024.112223. Epub 2024 May 20.
8
Analysis of Distribution and Drug Susceptibility Test Results of Pathogenic Bacteria in Diabetic Foot Ulcers.糖尿病足溃疡病原菌分布及药敏试验结果分析
Diabetes Ther. 2024 Jul;15(7):1627-1637. doi: 10.1007/s13300-024-01601-x. Epub 2024 May 21.
9
Strategies for combating antibiotic resistance in bacterial biofilms.对抗细菌生物膜中抗生素耐药性的策略。
Front Cell Infect Microbiol. 2024 Jan 19;14:1352273. doi: 10.3389/fcimb.2024.1352273. eCollection 2024.
10
Chronic Recurrent Multifocal Osteomyelitis.慢性复发性多灶性骨髓炎。
Med Clin North Am. 2024 Jan;108(1):227-239. doi: 10.1016/j.mcna.2023.05.022. Epub 2023 Jul 11.